Chemical composition and antifungal activity of essential oil of Hyssopus officinalis L. from Bulgaria against clinical isolates of Candida species

Biotechnology and Biotechnological Equipment

Volumn 29, Issue 3, 2015, Pages 592-601

  Hristova, Yana ^a   Wanner, Juergen ^b   Jirovetz, Leopold ^c   Stappen, Iris ^c   Iliev, Ivan ^a   Gochev, Velizar ^a  

^a UNIVERSITY OF PLOVDIV   (Bulgaria)

^b Kurt Kutzing Co   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antifungal activity; Candida; Clinical isolates; Essential oil; Hyssopus officinalis L

Indexed keywords

CANDIDA; CHEMICAL DETECTION; CHROMATOGRAPHY; FUNGI; GAS CHROMATOGRAPHY; IONIZATION OF GASES; MASS SPECTROMETRY; MONOTERPENES; OIL SHALE; YEAST;

ANTI-FUNGAL ACTIVITY; CANDIDA PARAPSILOSIS; CHEMICAL COMPOSITIONS; CHROMATOGRAPHIC COLUMN; CLINICAL ISOLATES; FLAME IONIZATION DETECTION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYSSOPUS OFFICINALIS L;

ESSENTIAL OILS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; HYSSOPUS OFFICINALIS; ISSATCHENKIA ORIENTALIS;

EID: 84928942845     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2015.1020341     Document Type: Article

References (54)

1. Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, Powderly WG, Hyslop N, Kauffman CA, Cleary J, Mangino JE, Lee J. Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother. 2003;47:3149-3154.
2. Posteraro B, Torelli R, De Carlos E, Posteraro P, Sanduinetti M. Antifungal susceptibility testing: current role from the clinical laboratory perspective. Mediterr J Hematol Infect Dis. 2014;6:e2014030.
3. Vázquez-Conzález D, Persguía-Ortiz AM, Hundeiker M, Bonifaz A. Opportunistic yeast in infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis. J Dtsch Dermatol Ges. 2013;11:381-395.
4. De Azevedo I, Semprebom AM, Baboni FB, Rosa RT, MacHado MAN, Samaranayake LP, Rosa EAR. Low virulent oral Candida albicans strains isolated from smokers. Arch Oral Biol. 2012;57:148-153.
5. Fu Y, Luo G, Spellberg B, Edwards J, Ibrahim A. Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans. Eukar Cell. 2008;7:483-492.
6. Kosalec I, Pepeljnjak S, Matica B, Jarža-Davila N. Virulence factors of yeast Candida albicans. Farm Glas. 2005;61:381-396.
7. Ramesh N, Priyadharsini M, Sumathi CS, Balasubramanian V, Hemapriya J, Kannan R. Virulence factors and antifungal sensitivity pattern of Candida spp. isolated from HIV and TB patients. Indian J Microbiol. 2011;51:273-278.
8. Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect. 2003;36:223-228.
9. Amar CS, Ashish J, Hajare V, Sreekantha, Yogesh B, Vinod C. Study of prevalence and antifungal susceptibility of Candida. Int J Pharma Bio Sci. 2013;4:361-381.
10. Carvalhinho S, Costa AM, Coelho AC, Martins E, Sampaio A. Susceptibilities of Candida albicans mouth isolates to antifungal agents, essential oils and mouth rinses. Mycopathologia. 2012;174:69-76.
11. Jerez-Puebla E, Fernández M, Illnait T, Perurena R, Rodríguez I, Martínez G. In vitro susceptilidad de C2ndida spp. 2isladas de la cavidad oral de pacientes VIH/sida a itraconazol, clotrimazol y ketoconazol [In vitro susceptibility of Candida spp. isolated from the oral cavity of HIV/ AIDS patients to itraconazole, clotrimazole and ketoconazole]. Arch Venez Farmacol Terap. 2012;31:80-84. Spanish.
12. Mahmoudabadi AZ, Zarrin M, Fard MB. Antifungal susceptibility of Candida species isolated from Candiduria. Jundishapur J Microbiol. 2013;6:24-48.
13. Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. Fluconazol-resistent Candida albicans vulvovaginitis. Obstet Gynecol. 2012;120:1407-1414.
14. Mulu A, Kassu A, Anagaw B, Moges B, Gelaw B, Alemayehu M, Belyhun Y, Biadglegne F, Hurissa Z, Moges F, Isogai E. Frequent detection of ázolé resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infect Dis. 2013;13:82.
15. Sharopov FS, Kukaniev MA, Thompson RM, Satyal P, Setzer WN. Composition and antimicrobial activity of the essential oil of Hyssopus seravshanicus growing wild in Tajikistan. Der Pharma Chemica. 2012;4:961-966.
16. Asadi-Pooya AA, Nikseresht AR, Yaghoubi E. Old remedies for epilepsy: Avicenna's medicine. Iran Red Cres Med J. 2012;14:174-177.
17. Dehghanzadeh N, Ketabchi S, Alizadeh A. Essential oil composition and antibacterial activity of Hyssopus officinalis L. growning in Iran. Asian J Exp Biol Sci. 2012;3:767-771.
18. Fathiazad F, Hamedeyazdan S. A review on Hysssopus officinaliis L.: Composition and biological activities. J Pharm Pharmacol. 2011;5:1959-1966.
19. Kizil S, Haşimi N, Tolan V, Kilini E., Karataş H. Chemical composition, antimicrobial and antioxidant activities of hyssop (Hyssopus officinalis L.) essential oil. Not Bot Hort Agrobot Cluj-Napoca. 2010;38:99-10.
20. Fraternale D, Ricci D, Epifano F, Curini M. Composition and antifungal activity of two essential oils of hyssop (Hyssopus officinalis L.). J Essent Oil Res. 2004;16:617-622.
21. Garcia-Vallejo MC, Guijarro-Herraiz J, Perez-Alonso MJ, Velasco-Negueruela A. Volatile oil of Hyssopus officinalis L. from Spain. J Essent Oil Res. 1995;7:567-568.
22. Glamoćlija J, Soković M, Vukojevic J, Milencovic I, Brkic D, van Griensven LJLD. Antifungal activity of essential oil Hyssopus officinalis L. against mycopathogen Mycogone perniciosa (MANG). Matica Srpska J Nat Sci. 2005;109:123-128.
23. Manitto P, Hadjieva B, Hadjieva P, Zlatkovska E, Tzvetkova A. Gas chromatography-mass spectral analysis of Bulgarian and Italian essential oils from Hyssopus officinalis L. Bulg Chem Ind. 2004;75:89-95.
24. Mitić V, Dordevic S. Essential oil composition of Hyssopus officinalis L. cultivated in Serbia. Phys Chem Technol. 2000;2:105-108.
25. Mohan M, Seth R, Singh P, Lohani H, Gupta S. Composition of the volatiles of Hyssopus officinalis (L.) from Uttarakhand Himalaya. Nat Acad Sci Lett. 2012;35:445-448.
26. Özer H, Sokmen M, Gulluce M, Adiguzel A, Kilic A, Sahin F, Sokmen A, Baris O. In vitro antimicrobial and antioxidant activities of the essential oils and methanol extracts of Hyssopus officinalis L. spp angustifolius. Ital J Food Sci. 2006;18:73-83.
27. Wesolowska A, Jadczak D, Grezeszuk M. Essential oil composition of hyssop (Hyssopus officinalis L.) cultivated in north-western Poland. Herba Pol. 2010;56:57-65.
28. Kazazi H, Rezaei K, Ghotbsharif S, Emamdjomeh Z, Yamini Y. Supercritical fluid extraction of flavors and fragrances from Hyssopus officinalis L. cultivated in Iran. Food Chem. 2007;105:805-811.
29. Langa E, Cacho J, Palavra AMF, Burillo J, Mainar AM, Urieta JS. The evolution of hyssop oil composition in the supercritical extraction curve modelling of the oil extraction process. J Supercrit Fluids. 2009;49:37-44.
30. Moro A, Zalacain A, De Mendoza JH, Carmona M. Effects of agronomic practices on volatile composition of Hysssopus officinalis L. essential oils. Molecules. 2011;16:4131-4139.
31. Mazzanti G, Battinelli L, Salvatore G. Antimicrobial properties of the linalool-rich essential oil of Hyssopus officinalis L. var decumbens (Lamiaceae). Flavour Fragr J. 1998;13:289-294.
32. Renzini G, Scazzocchio F, Lu M, Mazzanti G, Salvatore G. Antibacterial and cytotoxic activity of Hyssopus officinalis L. oils. J Essent Oil Res. 1991;11:649-654.
33. Letessier MP, Svoboda KP, Walters DR. Antifungal activity of the essential oil of hyssop (Hyssopuss officinalis). J Phytopathol. 2001;149:673-678.
34. Moro A, Librán CM, Berruga MI, Zalacain A, Carmona M. Mycotoxicogenic fungal inhibition by innovative cheese cover aromatic plants. J Sci Technol Agric. 2013;93:1112-1118.
35. Mousavi SM, Raftos D. In viro antifungal activity of a new combination of essential oils against some filamentous fungi. Middle East J Sci Res. 2012;11:156-161.
36. Marino M, Bersani C, Comi G. Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int J Food Microbiol. 2001;67:187-195.
37. Mahboubi M, Kazempour N. In vitro antimicrobial activity of some essential oils from Labiatae Family. J Essent Oil Bear Pl. 2009;12:494-508.
38. The National Institute of Standards and Technology/ National Institute of Health/Environmental Protect Agency/ Mass Spectral Library (Upgrade). John Wiley & Sons; 2008.
39. Adams RP. Identification of essential oil components by gas chromatography/quadrupole mass spectroscopy. 4th ed. Carol Stream, IL: Allured; 2007.
40. Jennings W, Shibamoto T. Qualitative analysis of flavour and fragrance volatiles by glass capillary gas chromatography. New York, NY: Academic Press; 1980.
41. Julian D, Konig WA. The Atlas of Spectral Data of Sesquiterpene Hydrocarbons. Hamburg: E.B. Verlag; 1988.
42. Kondjoyan N, Berdagué JL. A compilation of relative retention indices for the analysis of aromatic compounds. Theix: Laboratoire Flavour; 1996.
43. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. 3rd ed. CLSI document M27-A3. Wayene, PA: CLSI; 2008.
44. Lunde CS, Kubo I. Effect of polygodial on the Mitochondrial ATPase of Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2000;44:1943-1953.
45. Ostroumova OS, Efimova SS, Chulkov EG, Schagina LV. The interaction of dipole modifiers with polyene-sterol complexes. PLo S One. 2012;7(9):e45135. doi: 10.1371/ journal.pone.0045135
46. Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36:187-191.
47. Cox SD, Mann CM, Markham JL. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol. 2000;88: 170-175.
48. Laroche C, Beney L, Marechal PA, Gervas P, The effect of osmotic pressure on the membrane fluidity of Saccharomyces cerevisiae at different physiological temperatures. Appl Microbiol Biotechnol. 2001;56:249-254.
49. Pina-Vaz C, Rodrigues AG, Sansonetty F, Martinez-De-Oliveira J, Fonseca AF, Må rdh PA. Antifungal activity of local anesthetics against Candida species. Infect Dis Obstet Gynecol. 2000;8:124-137.
50. Chambel A, Viegas CA, Sá-Correia I. Effect of cinnamic acid on the growth and on plasma membrane H C-ATPase activity of Saccharomyces cerevisiae. Int J Food Microbiol. 1999;50:173-179.
51. Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents. 2008;31:472-477.
52. Hammer KA, Carson CF, Riley TV. Melaleuca alternifolia (tee tree) oil inhibits germ tube formation by Candida albicans. Med Mycol. 2000;38:355-361.
53. Tampieri MP, Galuppi R, Macchioni F, Carelle MS, Falcioni L, Cioni PL, Morelli I. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia. 2005;159:339-345.
54. Ultee A, Slump RA, Steging G, Smid EJ. Antimicrobial activity of carvacrol toward Bacillus cereus on rice. J Food Prot. 2000;63:620-624.